Literature DB >> 25991703

Porcine models of muscular dystrophy.

Joshua T Selsby1, Jason W Ross1, Dan Nonneman1, Katrin Hollinger1.   

Abstract

Duchenne muscular dystrophy is a progressive, fatal, X-linked disease caused by a failure to accumulate the cytoskeletal protein dystrophin. This disease has been studied using a variety of animal models including fish, mice, rats, and dogs. While these models have contributed substantially to our mechanistic understanding of the disease and disease progression, limitations inherent to each model have slowed the clinical advancement of therapies, which necessitates the development of novel large-animal models. Several porcine dystrophin-deficient models have been identified, although disease severity may be so severe as to limit their potential contributions to the field. We have recently identified and completed the initial characterization of a natural porcine model of dystrophin insufficiency. Muscles from these animals display characteristic focal necrosis concomitant with decreased abundance and localization of dystrophin-glycoprotein complex components. These pigs recapitulate many of the cardinal features of muscular dystrophy, have elevated serum creatine kinase activity, and preliminarily appear to display altered locomotion. They also suffer from sudden death preceded by EKG abnormalities. Pig dystrophinopathy models could allow refinement of dosing strategies in human-sized animals in preparation for clinical trials. From an animal handling perspective, these pigs can generally be treated normally, with the understanding that acute stress can lead to sudden death. In summary, the ability to create genetically modified pig models and the serendipitous discovery of genetic disease in the swine industry has resulted in the emergence of new animal tools to facilitate the critical objective of improving the quality and length of life for boys afflicted with such a devastating disease. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Becker muscular dystrophy; DMD; Duchenne muscular dystrophy; disease model; dystrophin; mdx; pig

Mesh:

Substances:

Year:  2015        PMID: 25991703      PMCID: PMC4542708          DOI: 10.1093/ilar/ilv015

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  100 in total

1.  Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.

Authors:  Mingju Liu; Yongping Yue; Scott Q Harper; Robert W Grange; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

2.  Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

Authors:  Liangxue Lai; Donna Kolber-Simonds; Kwang-Wook Park; Hee-Tae Cheong; Julia L Greenstein; Gi-Sun Im; Melissa Samuel; Aaron Bonk; August Rieke; Billy N Day; Clifton N Murphy; David B Carter; Robert J Hawley; Randall S Prather
Journal:  Science       Date:  2002-01-03       Impact factor: 47.728

Review 3.  The role of free radicals in the pathophysiology of muscular dystrophy.

Authors:  James G Tidball; Michelle Wehling-Henricks
Journal:  J Appl Physiol (1985)       Date:  2006-11-09

4.  Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.

Authors:  O Tutdibi; H Brinkmeier; R Rüdel; K J Föhr
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

5.  Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.

Authors:  Jérémy Fauconnier; Jérôme Thireau; Steven Reiken; Cécile Cassan; Sylvain Richard; Stefan Matecki; Andrew R Marks; Alain Lacampagne
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

6.  New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

Authors:  G A Cox; S F Phelps; V M Chapman; J S Chamberlain
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

7.  The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.

Authors:  Joe N Kornegay; Diane D Cundiff; Daniel J Bogan; Janet R Bogan; Carol S Okamura
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

8.  Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.

Authors:  S J Schatzberg; L V Anderson; S D Wilton; J N Kornegay; C J Mann; G G Solomon; N J Sharp
Journal:  Muscle Nerve       Date:  1998-08       Impact factor: 3.217

9.  MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.

Authors:  M S Alexander; G Kawahara; N Motohashi; J C Casar; I Eisenberg; J A Myers; M J Gasperini; E A Estrella; A T Kho; S Mitsuhashi; F Shapiro; P B Kang; L M Kunkel
Journal:  Cell Death Differ       Date:  2013-06-14       Impact factor: 15.828

10.  Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.

Authors:  D J Law; D L Allen; J G Tidball
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

View more
  15 in total

Review 1.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

2.  Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy.

Authors:  Thomas Fröhlich; Elisabeth Kemter; Florian Flenkenthaler; Nikolai Klymiuk; Kathrin A Otte; Andreas Blutke; Sabine Krause; Maggie C Walter; Rüdiger Wanke; Eckhard Wolf; Georg J Arnold
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

3.  The porcine translational research database: a manually curated, genomics and proteomics-based research resource.

Authors:  Harry D Dawson; Celine Chen; Brady Gaynor; Jonathan Shao; Joseph F Urban
Journal:  BMC Genomics       Date:  2017-08-22       Impact factor: 3.969

Review 4.  The golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay
Journal:  Skelet Muscle       Date:  2017-05-19       Impact factor: 4.912

Review 5.  Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.

Authors:  Merryl Rodrigues; Yusuke Echigoya; So-Ichiro Fukada; Toshifumi Yokota
Journal:  J Neuromuscul Dis       Date:  2016-03-03

6.  A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.

Authors:  Sara Mata López; James J Hammond; Madison B Rigsby; Cynthia J Balog-Alvarez; Joe N Kornegay; Peter P Nghiem
Journal:  Skelet Muscle       Date:  2018-05-29       Impact factor: 4.912

7.  Simvastatin Impairs the Inflammatory and Repair Phases of the Postinjury Skeletal Muscle Regeneration.

Authors:  Iwona Otrocka-Domagała; Katarzyna Paździor-Czapula; Tomasz Maślanka
Journal:  Biomed Res Int       Date:  2018-11-04       Impact factor: 3.411

8.  Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  John C W Hildyard; Amber M Finch; Dominic J Wells
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

9.  Genome-wide analysis of genetic diversity and artificial selection in Large White pigs in Russia.

Authors:  Siroj Bakoev; Lyubov Getmantseva; Olga Kostyunina; Nekruz Bakoev; Yuri Prytkov; Alexander Usatov; Tatiana V Tatarinova
Journal:  PeerJ       Date:  2021-07-02       Impact factor: 2.984

Review 10.  iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies.

Authors:  Jose L Ortiz-Vitali; Radbod Darabi
Journal:  Cells       Date:  2019-01-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.